Overview

Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction

Status:
Completed
Trial end date:
2017-06-30
Target enrollment:
Participant gender:
Summary
Tramadol (Tradol) and ketorolac (Dolac) are marketed products to treat acute pain. This study was performed to determine if both medications can be given to a patient simultaneously without a change of the products' bioavailability.
Phase:
Phase 1
Details
Lead Sponsor:
Grünenthal GmbH
Collaborators:
Grünenthal Colombiana S.A.
Grünenthal S.A.
Treatments:
Ketorolac
Ketorolac Tromethamine
Tramadol